Agomelatine: innovation for the benefit of depressed patients.
Rouillon
Frédéric
F
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy / Q000503:physiopathology; D009281:Naphthalenes
D000081:Acetamides; D000928:Antidepressive Agents; C084711:agomelatine; D009281:Naphthalenes